BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in BioAtla, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −15 vs. Q1 2026
- Shares held
- 295.5K
- −17.8K (−5.7%) vs. Q1 2026Converted for a 1-for-50 split
- Total value
- $1.22M
- −$1.29M (−51.5%) vs. Q1 2026
- New holders
- 4
- 5 more added
- Sold out
- 19
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.22M |
| Q1 2026 | 36 | $2.52M |
| Q4 2025 | 41 | $7.49M |
| Q3 2025 | 43 | $9.19M |
| Q2 2025 | 39 | $5.21M |
| Q1 2025 | 43 | $4.77M |
| Q4 2024 | 67 | $14.2M |
| Q3 2024 | 65 | $31.0M |
| Q2 2024 | 80 | $30.4M |
| Q1 2024 | 84 | $87.2M |
| Q4 2023 | 79 | $66.6M |
| Q3 2023 | 82 | $51.3M |
| Q2 2023 | 87 | $96.1M |
| Q1 2023 | 81 | $87.6M |
| Q4 2022 | 91 | $279.2M |
| Q3 2022 | 73 | $191.5M |
| Q2 2022 | 80 | $67.1M |
| Q1 2022 | 97 | $127.7M |
| Q4 2021 | 81 | $518.4M |
| Q3 2021 | 87 | $746.4M |
| Q2 2021 | 76 | $897.0M |
| Q1 2021 | 62 | $964.6M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BioAtla, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 7 | $29 | 0.00% | −2−25.8% | ReducedConverted for a 1-for-50 split |
| Jones Financial Companies LLLP | 40 | $147 | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Barclays PLC | 101 | $418 | 0.00% | +101 | New |
| JPMorgan Chase & Co | 121 | $464 | 0.00% | +118+4,589.9% | AddedConverted for a 1-for-50 split |
| Twin Lakes Capital Management, LLC | 144 | $596 | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Forum Finance Group S.A. | 400 | $1.00K | 0.00% | +400 | New |
| SBI Securities Co., Ltd. | 267 | $1.10K | 0.00% | +45+20.0% | AddedConverted for a 1-for-50 split |
| Tower Research Capital LLC (TRC) | 863 | $3.57K | 0.00% | +523+153.9% | AddedConverted for a 1-for-50 split |
| Morgan Stanley | 1,108 | $4.59K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Vanguard Fiduciary Trust Co | 4,730 | $19.6K | 0.00% | −739−13.5% | ReducedConverted for a 1-for-50 split |
| UBS Group AG | 6,201 | $25.7K | 0.00% | −1,310−17.4% | ReducedConverted for a 1-for-50 split |
| Vanguard Capital Management LLC | 9,164 | $37.9K | 0.00% | −23,821−72.2% | ReducedConverted for a 1-for-50 split |
| BlackRock, Inc. | 9,616 | $39.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Deutsche Bank AG | 10,556 | $43.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Geode Capital Management, LLC | 12,819 | $53.1K | 0.00% | −965−7.0% | ReducedConverted for a 1-for-50 split |
| HRT Financial LP | 13,276 | $54.0K | 0.00% | +13,276 | New |
| Acadian Asset Management LLC | 14,294 | $58.0K | 0.00% | −10,384−42.1% | ReducedConverted for a 1-for-50 split |
| Stonepine Capital Management, LLC | 16,432 | $68.0K | 0.05% | +15,124+1,156.5% | AddedConverted for a 1-for-50 split |
| Lido Advisors, LLC | 16,656 | $69.0K | 0.00% | +16,656 | New |
| Millennium Management LLC | 70,616 | $292.4K | 0.00% | +15,483+28.1% | AddedConverted for a 1-for-50 split |
| Acorn Capital Advisors, LLC | 108,126 | $447.6K | 0.12% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,210−100.0% | Sold outConverted for a 1-for-50 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −8,714−100.0% | Sold outConverted for a 1-for-50 split |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −5,553−100.0% | Sold outConverted for a 1-for-50 split |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −4,562−100.0% | Sold outConverted for a 1-for-50 split |
| State Street Corp | 0 | $0 | 0.00% | −3,028−100.0% | Sold outConverted for a 1-for-50 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,070−100.0% | Sold outConverted for a 1-for-50 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,478−100.0% | Sold outConverted for a 1-for-50 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,132−100.0% | Sold outConverted for a 1-for-50 split |
| MAI Capital Management | 0 | $0 | 0.00% | −1,030−100.0% | Sold outConverted for a 1-for-50 split |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −885−100.0% | Sold outConverted for a 1-for-50 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −781−100.0% | Sold outConverted for a 1-for-50 split |
| StoneX Group Inc. | 0 | $0 | 0.00% | −589−100.0% | Sold outConverted for a 1-for-50 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −506−100.0% | Sold outConverted for a 1-for-50 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −463−100.0% | Sold outConverted for a 1-for-50 split |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-50 split |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −333−100.0% | Sold outConverted for a 1-for-50 split |
| Mariner, LLC | 0 | $0 | 0.00% | −320−100.0% | Sold outConverted for a 1-for-50 split |
| Torrey Growth & Income Advisors | 0 | $0 | 0.00% | −314−100.0% | Sold outConverted for a 1-for-50 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-50 split |